Literature DB >> 12618855

Toll-like receptors and their role in experimental models of microbial infection.

Salman T Qureshi1, R Medzhitov.   

Abstract

Effective host defense against microbial infection depends upon prompt recognition of pathogens, activation of immediate containment measures, and ultimately the generation of a specific and definitive adaptive immune response. The innate immune system of the host is responsible for providing constant surveillance against infection; when confronted by pathogens it deploys a series of rapidly acting antimicrobial effectors while simultaneously instructing the adaptive immune system as to the nature and context of the infectious threat. Pathogen recognition and activation of innate immunity is mediated by members of the Toll-like receptor (TLR) family through detection of conserved microbial structures that are absent from the host. Experimental models of infection using TLR-deficient mice, as well as limited human studies, have clearly demonstrated the critical role of TLRs in host defense against most major groups of mammalian pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618855     DOI: 10.1038/sj.gene.6363937

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  42 in total

1.  Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia.

Authors:  Tammy Kielian; Nilufer Esen; Edward D Bearden
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

2.  Toll-like receptor 4-dependent early elicited tumor necrosis factor alpha expression is critical for innate host defense against Bordetella bronchiseptica.

Authors:  Paul B Mann; Kelly D Elder; Mary J Kennett; Eric T Harvill
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 3.  Worms and flies as genetically tractable animal models to study host-pathogen interactions.

Authors:  Eleftherios Mylonakis; Alejandro Aballay
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

4.  Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release.

Authors:  Mikhail A Gavrilin; Imad J Bouakl; Nina L Knatz; Michelle D Duncan; Mark W Hall; John S Gunn; Mark D Wewers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-22       Impact factor: 11.205

Review 5.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

6.  Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection.

Authors:  Paul B Mann; Daniel Wolfe; Eicke Latz; Douglas Golenbock; Andrew Preston; Eric T Harvill
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

7.  Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.

Authors:  Nadra J Nilsen; Susanne Deininger; Unni Nonstad; Frode Skjeldal; Harald Husebye; Dmitrii Rodionov; Sonja von Aulock; Thomas Hartung; Egil Lien; Oddmund Bakke; Terje Espevik
Journal:  J Leukoc Biol       Date:  2008-05-05       Impact factor: 4.962

8.  Exposure to Cigarette Smoke Disrupts CCL20-Mediated Antimicrobial Activity in Respiratory Epithelial Cells.

Authors:  Mardi A Crane-Godreau; Matthew A Maccani; Susan K Eszterhas; Sandra L Warner; James A Jukosky; Steven Fiering
Journal:  Open Immunol J       Date:  2009-01-01

9.  Regulation of TLR2 expression and function in human airway epithelial cells.

Authors:  Tamene Melkamu; Diane Squillace; Hirohito Kita; Scott M O'Grady
Journal:  J Membr Biol       Date:  2009-06-10       Impact factor: 1.843

10.  Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense.

Authors:  Luis B Barreiro; Meriem Ben-Ali; Hélène Quach; Guillaume Laval; Etienne Patin; Joseph K Pickrell; Christiane Bouchier; Magali Tichit; Olivier Neyrolles; Brigitte Gicquel; Judith R Kidd; Kenneth K Kidd; Alexandre Alcaïs; Josiane Ragimbeau; Sandra Pellegrini; Laurent Abel; Jean-Laurent Casanova; Lluís Quintana-Murci
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.